Literature DB >> 33239550

The association between indices of blood pressure waveforms (PTC1 and PTC2) and incident heart failure.

Lyndia C Brumback1, Leah I B Andrews1, David R Jacobs2, Daniel A Duprez3, Sanjiv J Shah4, Cynthia M Dougherty5, Julie O Denenberg6, Matthew A Allison6.   

Abstract

OBJECTIVES: The radial artery pulse waveform is a continuous measure of pressure throughout the cardiac cycle, and thus can provide more information than just systolic and diastolic blood pressures. New indices based on a Windkessel model of the waveform, PTC1 and PTC2, are related to arterial compliance and add information for prediction of incident cardiovascular disease (coronary heart disease, stroke, myocardial infarction) but their association with heart failure is unknown.
METHODS: Among 6229 adults (mean age 62 years) from four race/ethnic groups who were initially free of clinical cardiovascular disease and heart failure in 2000-2002, we evaluated the associations of baseline PTC1 and PTC2 with incident heart failure.
RESULTS: Mean ± standard deviation PTC1 and PTC2 were 394 ± 334 and 94 ± 46 ms, respectively. During a median of 15.7 years follow-up, there were 357 heart failure events (148 with reduced, 150 with preserved, and 59 with unknown ejection fraction). After adjustment for traditional risk factors, the hazard ratio for heart failure per 1 standard deviation higher PTC2 was 0.73 (95% confidence interval: 0.63--0.85). Higher PTC2 was also significantly associated with lower risk of heart failure with reduced ejection fraction (hazard ratio = 0.67; 95% confidence interval: 0.56--0.80). There was no evidence of a significant association between PTC2 and heart failure with preserved ejection fraction or between PTC1 and heart failure.
CONCLUSION: The PTC2 measure of the radial artery pulse waveform may represent a novel phenotype related to heart failure, especially heart failure with reduced ejection fraction.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33239550      PMCID: PMC8177733          DOI: 10.1097/HJH.0000000000002707

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  20 in total

Review 1.  Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures.

Authors:  Luc M Van Bortel; Daniel Duprez; Mirian J Starmans-Kool; Michel E Safar; Christina Giannattasio; John Cockcroft; Daniel R Kaiser; Christian Thuillez
Journal:  Am J Hypertens       Date:  2002-05       Impact factor: 2.689

2.  Report of the expert committee on the diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

3.  Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.

Authors:  Jennifer E Ho; Asya Lyass; Douglas S Lee; Ramachandran S Vasan; William B Kannel; Martin G Larson; Daniel Levy
Journal:  Circ Heart Fail       Date:  2012-12-27       Impact factor: 8.790

4.  Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao
Journal:  Circulation       Date:  2020-01-29       Impact factor: 29.690

5.  Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).

Authors:  Ambarish Pandey; Hassan Khan; Anne B Newman; Edward G Lakatta; Daniel E Forman; Javed Butler; Jarett D Berry
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

6.  The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

Authors:  Andrew P Ambrosy; Gregg C Fonarow; Javed Butler; Ovidiu Chioncel; Stephen J Greene; Muthiah Vaduganathan; Savina Nodari; Carolyn S P Lam; Naoki Sato; Ami N Shah; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2014-02-05       Impact factor: 24.094

7.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

8.  PTC1 and PTC2: New Indices of Blood Pressure Waveforms and Cardiovascular Disease.

Authors:  Lyndia C Brumback; David R Jacobs; Daniel A Duprez
Journal:  Am J Epidemiol       Date:  2020-07-01       Impact factor: 4.897

9.  Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis).

Authors:  Julio A Chirinos; Jan G Kips; David R Jacobs; Lyndia Brumback; Daniel A Duprez; Richard Kronmal; David A Bluemke; Raymond R Townsend; Sebastian Vermeersch; Patrick Segers
Journal:  J Am Coll Cardiol       Date:  2012-10-24       Impact factor: 24.094

10.  Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Daniel A Duprez; Myron D Gross; Jorge R Kizer; Joachim H Ix; William G Hundley; David R Jacobs
Journal:  J Am Heart Assoc       Date:  2018-02-23       Impact factor: 5.501

View more
  1 in total

1.  Bazedoxifene activates the angiotensin II-induced HUVEC hypertension model by targeting SIRT1.

Authors:  Qian Yu; Jin Zhao; Baotang Liu
Journal:  Exp Ther Med       Date:  2021-12-07       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.